Polls show almost 90% of Americans are in favor of medicinal marijuana. In an increasingly fractured country, it’s hard to find anything that many Americans believe. With the midterm elections fast approaching, you can bet candidates will champion this cause and this will lead to a pretty strong mandate.
Smart investors are hopping on bargains in these sectors as they can see the writing on the wall.
A small biotech company that we have discovered is BRTX (BioRestorative Therapies, Inc.). Start researching BRTX for yourself immediately. BRTX is a stem cell company, that is up nearly 100% in the last 5 sessions. BRTX is preparing for its phase 2 clinical trial using BRTX-100. Everyone that discovers BRTX before the phase 2 clinical trial starts could be in store for a great win. There are several other companies making major gains we’ve listed below.
New York Governor Andrew Cuomo has reportedly taken another step toward legalizing marijuana in the state announcing Thursday that he has appointed a panel to draft legislation to legalize marijuana in the State of New York. In doing so, Cuomo seemed to further demonstrate a willingness to weigh in on an issue that has plagued New Yorkers for decades, and which the incumbent governor has seemingly rushed to catch up on since gubernatorial primary challenger Cynthia Nixon picked up the issue earlier this year.
This has renewed interest in Biotech as well. Major announcements like this will help people invested in companies line their wallets in the coming months.
Some companies set to benefit from this news include: BioRestorative Therapies, Inc. (BRTX), CV Sciences, Inc. (CVSI), Aurora Cannabis (ACBFF), Aphria, Inc. (APHQF), and Insys Therapeutics, Inc. (HYYDF).
BioRestorative Therapies, Inc. (BRTX)
Market Cap: $24.99M Share Price: $3.76
BioRestorative Therapies, Inc. (BRTX), a life sciences company focused on stem cell-based therapies, recently announced the appointment of Jason S. Lipetz, M.D. to the Company’s Scientific Advisory Board. Dr. Lipetz has an impressive resume and investors appear to be paying attention to the Company sending the stock up over 100% in the past 5 sessions.
CV Sciences, Inc. (CVSI)
Market Cap: $282.86M Share Price: $3.12
CV Sciences, Inc. is a supplier and manufacturer of hemp-based phytocannabinoids including cannabidiol (CBD) oil and developer of specialty pharmaceutical therapeutics. The Company recently had news showing unaudited second quarter 2018 revenue. Second quarter 2018 revenue is expected to be USD 12.3 Million, up over 200% to the second quarter of 2017.
Aurora Cannabis (ACBFF)
Market Cap: $2.94B Share Price: $5.16
Aurora Cannabis Inc. (ACBFF) has received quite a bit of investor interest after announcing a Letter of Intent to establish one of the first medical cannabis production facilities in Malta. The Company received a Letter of Intent from Malta Enterprise for the establishment of a seed-to-pharma cannabis operation, including the construction of a hybrid production facility that will be focused predominantly on the production of oils and derivatives. Operations will be carried out by a new company, to be formed by Aurora and its local partner Cherubino Ltd., the largest pharmaceutical wholesaler in Malta with an operating history of over 100 years. Aurora will be the majority shareholder in the new venture.
Aphria, Inc. (APHQF)
Market Cap: $1.89B Share Price: $8.07
Aphira, Inc. (APHQF) a leading global cannabis company investing in targeted, measured and ROI proven investments in its growing portfolio of recreational brands just announced quarterly revenue highlighted by adjusted gross margin increases to 78.7% of revenue. It was Industry leading eleventh consecutive quarter of positive adjusted EBITDA from ACMPR operations.
The Hydropothecary Corporation (HYYDF)
Market Cap: $702.64M Share Price: $3.62
Is one of a relatively short list of Canadian cannabis producers set up to on track to produce in excess of 100,000 kilograms of cannabis when at full capacity. The company has been a major winner with Canada’s new recreational cannabis laws.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and nine thousand dollars total by Regal Consulting, LLC, for BRTX. BRTX and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article’s distribution.
For Full Legal Disclaimer Click Here.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States